COMMUNIQUÉS West-GlobeNewswire

Deaconess Standardizes Scheduling and Communications Operations with PerfectServe
06/10/2026
Health system establishes a centralized foundation for care team availability, operator workflows, and omnichannel communication EVANSVILLE, Ind. and MIAMI, Oct. 06, 2026 (GLOBE NEWSWIRE) -- PerfectServe®, a healthcare [...]
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
06/10/2026
PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio’s drug discovery models MENLO PARK, Calif. and PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the [...]
NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt
06/10/2026
Roth Capital’s recent Buy initiation adds to the Anticipation Surrounding Expected October FDA discussion and NeOnc’s scheduled November 17 meeting DENVER, Oct. 06, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- A [...]
Nelipak Wins 2026 DuPont™ Tyvek® Sustainable Healthcare Packaging Award for Sustainability In-use
06/10/2026
Nelipak’s Ecovate™ header bag, featuring all-polyethylene construction and Tyvek® with Renewable Attribution, recognized for helping the growing ready-to-fill/use market advance packaging circularity. CRANSTON, R.I., [...]
Confluent Health Names Tony Kaczkowski CEO of Industrial Health & Safety Solutions Division
06/10/2026
LOUISVILLE, Ky. -- Oct. 6, 2026, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Confluent Health , a national leader in musculoskeletal (MSK) care, today announced that Tony Kaczkowski has been named Chief Executive Officer (CEO) of [...]
Medline to report third quarter 2026 results on November 4, 2026
06/10/2026
NORTHFIELD, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report third quarter 2026 financial results on Wednesday, November 4, 2026. A press release [...]
PayZen Report: Costs Drive More Than 2 in 5 Patients Toward AI Instead of a Doctor
06/10/2026
PayZen’s State of Healthcare Affordability: The Patient Perspective 2026 focuses on addressing unaffordability, payment options and AI-powered financial guidance SAN FRANCISCO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Today, [...]
INmune Bio to Attend the 2026 Maxim Growth Summit
06/10/2026
BOCA RATON, FL, Oct. 06, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, is excited to announce its participation in [...]
Stride Autism Centers Becomes First and Only ACQ-Accredited ABA Therapy Provider in South Dakota
06/10/2026
Milestone recognition from the Autism Commission on Quality highlights Stride’s commitment to clinical excellence, safety, and family-centered care for young children with autism SIOUX FALLS, S.D., Oct. 06, 2026 (GLOBE [...]
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
06/10/2026
CALGARY, Alberta, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF) , and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug [...]
Nox Peptides Announces Launch of GHK-Cu and Wolverine Stack for Canadian Research Market
06/10/2026
TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Nox Peptides today announced the launch of two research-focused peptide products, GHK-Cu and the Wolverine Stack , expanding its product offering for Canadian laboratories, [...]
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
06/10/2026
Peer-Reviewed Paper Introduces QRX003 and Its Mechanism of Action in Netherton Syndrome Case Report Details Professor Alan Irvine’s Clinical Experience Treating a Pediatric Patient Under Quoin’s Compassionate Use [...]
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
06/10/2026
First doses of Pixclara administered in Cleveland (OH) and Indianapolis (IN) marking the start of U.S. commercial availability. Pixclara is the only FDA-approved radiopharmaceutical imaging drug for glioma (brain cancer [...]
MediciNova to Participate in the Maxim Growth Summit
06/10/2026
LA JOLLA, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
06/10/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe. The CARTIHEAL Implant will [...]
Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo.
06/10/2026
Smith+Nephew (LSE: SN, NYSE: SNN) azienda di tecnologia medica, annuncia il lancio commerciale in Europa di CARTIHEAL AGILI-C, l’innovativo impianto per la riparazione della cartilagine. La tecnologia sarà presentata [...]
Transactions in connection with share buy-back program
06/10/2026
Company announcement no. 38 - 26 06 October 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal
06/10/2026
Smith+Nephew (LSE: SN, NYSE: SNN), compañía global de tecnología médica, anuncia hoy que su innovador implante de reparación de cartílago CARTIHEAL AGILI-C ya está disponible para su comercialización en Europa. El [...]
Resolution Therapeutics to present interim Phase I/II EMERALD study data on RTX001 as a late-breaker at AASLD 2026
06/10/2026
Interim data from Phase I/II EMERALD study for RTX001, Resolution’s engineered Regenerative Macrophage Therapy, accepted as late-breaking presentation Dr. Lara Campana to present preclinical data on intravenous [...]

Pages